145 related articles for article (PubMed ID: 34628863)
1. Rufomycins or Ilamycins: Naming Clarifications and Definitive Structural Assignments.
Zhou B; Achanta PS; Shetye G; Chen SN; Lee H; Jin YY; Cheng J; Lee MJ; Suh JW; Cho S; Franzblau SG; Pauli GF; McAlpine JB
J Nat Prod; 2021 Oct; 84(10):2644-2663. PubMed ID: 34628863
[TBL] [Abstract][Full Text] [Related]
2. New Rufomycins from
Zhou B; Shetye G; Wolf NM; Chen SN; Qader M; Ray GJ; Lankin DC; Cho S; Cheng J; Suh JW; Franzblau SG; McAlpine JB; Pauli GF
Org Lett; 2022 Oct; 24(40):7265-7270. PubMed ID: 36194676
[TBL] [Abstract][Full Text] [Related]
3. Recent Developments on the Synthesis and Bioactivity of Ilamycins/Rufomycins and Cyclomarins, Marine Cyclopeptides That Demonstrate Anti-Malaria and Anti-Tuberculosis Activity.
Kazmaier U; Junk L
Mar Drugs; 2021 Aug; 19(8):. PubMed ID: 34436284
[TBL] [Abstract][Full Text] [Related]
4. Antimycobacterial Rufomycin Analogues from
Zhou B; Shetye G; Yu Y; Santarsiero BD; Klein LL; Abad-Zapatero C; Wolf NM; Cheng J; Jin Y; Lee H; Suh JW; Lee H; Bisson J; McAlpine JB; Chen SN; Cho SH; Franzblau SG; Pauli GF
J Nat Prod; 2020 Mar; 83(3):657-667. PubMed ID: 32031795
[TBL] [Abstract][Full Text] [Related]
5. Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents.
Ma J; Huang H; Xie Y; Liu Z; Zhao J; Zhang C; Jia Y; Zhang Y; Zhang H; Zhang T; Ju J
Nat Commun; 2017 Aug; 8(1):391. PubMed ID: 28855504
[TBL] [Abstract][Full Text] [Related]
6. Total Synthesis and Biological Evaluation of Modified Ilamycin Derivatives.
Greve J; Mogk A; Kazmaier U
Mar Drugs; 2022 Oct; 20(10):. PubMed ID: 36286456
[TBL] [Abstract][Full Text] [Related]
7. Structural Sequencing of Oligopeptides Aided by
Gao W; McAlpine JB; Choules MP; Napolitano JG; Lankin DC; Simmler C; Ho NA; Lee H; Suh JW; Burton IW; Cho S; Franzblau SG; Chen SN; Pauli GF
J Nat Prod; 2017 Oct; 80(10):2630-2643. PubMed ID: 29035048
[TBL] [Abstract][Full Text] [Related]
8. Rufomycin Targets ClpC1 Proteolysis in Mycobacterium tuberculosis and M. abscessus.
Choules MP; Wolf NM; Lee H; Anderson JR; Grzelak EM; Wang Y; Ma R; Gao W; McAlpine JB; Jin YY; Cheng J; Lee H; Suh JW; Duc NM; Paik S; Choe JH; Jo EK; Chang CL; Lee JS; Jaki BU; Pauli GF; Franzblau SG; Cho S
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30602512
[TBL] [Abstract][Full Text] [Related]
9. Antitubercular Ilamycins from Marine-Derived
Sun C; Liu Z; Zhu X; Fan Z; Huang X; Wu Q; Zheng X; Qin X; Zhang T; Zhang H; Ju J; Ma J
J Nat Prod; 2020 May; 83(5):1646-1657. PubMed ID: 32324401
[TBL] [Abstract][Full Text] [Related]
10. High-Resolution Structure of ClpC1-Rufomycin and Ligand Binding Studies Provide a Framework to Design and Optimize Anti-Tuberculosis Leads.
Wolf NM; Lee H; Choules MP; Pauli GF; Phansalkar R; Anderson JR; Gao W; Ren J; Santarsiero BD; Lee H; Cheng J; Jin YY; Ho NA; Duc NM; Suh JW; Abad-Zapatero C; Cho S
ACS Infect Dis; 2019 Jun; 5(6):829-840. PubMed ID: 30990022
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Regulatory and Transporter Genes in the Biosynthesis of Anti-Tuberculosis Ilamycins and Production in a Heterologous Host.
He J; Wei X; Yang Z; Li Y; Ju J; Ma J
Mar Drugs; 2020 Apr; 18(4):. PubMed ID: 32316457
[TBL] [Abstract][Full Text] [Related]
12. Computer-assisted
Gao W; Napolitano JG; Lankin DC; Kim JY; Jin YY; Lee H; Suh JW; Chen SN; Pauli GF
Magn Reson Chem; 2017 Mar; 55(3):239-244. PubMed ID: 27094011
[No Abstract] [Full Text] [Related]
13. Design, synthesis and evaluation against Mycobacterium tuberculosis of azole piperazine derivatives as dicyclotyrosine (cYY) mimics.
El-Wahab HAAA; Accietto M; Marino LB; McLean KJ; Levy CW; Abdel-Rahman HM; El-Gendy MA; Munro AW; Aboraia AS; Simons C
Bioorg Med Chem; 2018 Jan; 26(1):161-176. PubMed ID: 29183661
[TBL] [Abstract][Full Text] [Related]
14.
Perez Ortiz G; Sidda JD; de Los Santos ELC; Hubert CB; Barry SM
Chem Commun (Camb); 2021 Nov; 57(89):11795-11798. PubMed ID: 34676855
[TBL] [Abstract][Full Text] [Related]
15. Total synthesis of cyclomarins A, C and D, marine cyclic peptides with interesting anti-tuberculosis and anti-malaria activities.
Barbie P; Kazmaier U
Org Biomol Chem; 2016 Jul; 14(25):6036-54. PubMed ID: 27241518
[TBL] [Abstract][Full Text] [Related]
16. Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain.
Cai G; Napolitano JG; McAlpine JB; Wang Y; Jaki BU; Suh JW; Yang SH; Lee IA; Franzblau SG; Pauli GF; Cho S
J Nat Prod; 2013 Nov; 76(11):2009-18. PubMed ID: 24224794
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization and evaluation of antituberculosis activity of some hydrazones.
Koçyiğit KB; Rollas S
Farmaco; 2002 Jul; 57(7):595-9. PubMed ID: 12164221
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vitro antitubercular evaluation of novel sansanmycin derivatives.
Li YB; Xie YY; Du NN; Lu Y; Xu HZ; Wang B; Yu Y; Liu YX; Song DQ; Chen RX
Bioorg Med Chem Lett; 2011 Nov; 21(22):6804-7. PubMed ID: 21982497
[TBL] [Abstract][Full Text] [Related]
19. Residual Complexity Does Impact Organic Chemistry and Drug Discovery: The Case of Rufomyazine and Rufomycin.
Choules MP; Klein LL; Lankin DC; McAlpine JB; Cho SH; Cheng J; Lee H; Suh JW; Jaki BU; Franzblau SG; Pauli GF
J Org Chem; 2018 Jun; 83(12):6664-6672. PubMed ID: 29792329
[TBL] [Abstract][Full Text] [Related]
20. Antimycobacterial physalins from Physalis angulata L. (Solanaceae).
Januário AH; Filho ER; Pietro RC; Kashima S; Sato DN; França SC
Phytother Res; 2002 Aug; 16(5):445-8. PubMed ID: 12203265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
